These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17545102

  • 1. Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia.
    Ikram H, Samad N, Haleem DJ.
    Pak J Pharm Sci; 2007 Jul; 20(3):188-95. PubMed ID: 17545102
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat.
    Samad N, Haleem DJ.
    Acta Neurol Belg; 2009 Mar; 109(1):24-31. PubMed ID: 19402569
    [Abstract] [Full Text] [Related]

  • 4. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ, Samad N, Haleem MA.
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [Abstract] [Full Text] [Related]

  • 5. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK.
    Synapse; 2004 Dec 01; 54(3):156-63. PubMed ID: 15452862
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M, Chopra K, Kulkarni SK.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):55-66. PubMed ID: 17064683
    [Abstract] [Full Text] [Related]

  • 9. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.
    Rosengarten H, Bartoszyk GD, Quartermain D, Lin Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 15; 30(2):273-9. PubMed ID: 16229932
    [Abstract] [Full Text] [Related]

  • 10. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O, Haleem DJ, Saify ZS, Kamil N, Obaid R, Ahmed SW.
    Pak J Pharm Sci; 2005 Apr 15; 18(2):23-8. PubMed ID: 16431394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M, Chopra K, Kulkarni SK.
    Methods Find Exp Clin Pharmacol; 2007 Apr 15; 29(3):211-6. PubMed ID: 17520104
    [Abstract] [Full Text] [Related]

  • 13. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M, Kumar A, Chopra K, Kulkarni SK.
    Indian J Exp Biol; 2007 Feb 15; 45(2):175-9. PubMed ID: 17375557
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M, Chopra K, Kulkarni SK.
    Pharmacology; 2007 Feb 15; 79(3):171-83. PubMed ID: 17377417
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1130-8. PubMed ID: 17513028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.